clinical evidence raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-04-26 and is reviewed periodically as new material appears.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
| Property | Value | Notes |
|---|---|---|
| Origin | Fragment of a protein found in human gastric juice | Sequence corresponds to a fifteen-residue portion of the parent protein |
| Sequence | GEPPPGKPADDAGLV | Single linear chain, fifteen amino acids |
| Reported molecular weight | About 1419 daltons | Value quoted consistently in supplier and review literature |
| Regulatory status | Not an approved human medicine in the US or EU | Handled and sold as a research chemical |
| Sports status | Listed as prohibited | Falls under non-approved-substance categories in anti-doping codes |
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
== Personal life == Kennedy and his wife, Becky, are founding members of their local Methodist church in Madisonville. Despite sharing the first and last name of the 35th president of the United States, he is not related to the Kennedy family of Massachusetts. Members of Kennedy's family were slaveowners before the Civil War, and have been political and economic elites in Louisiana since the 19th century. Kennedy's great-great-great-grandfather enslaved 120 people in Catahoula and Concordia Parishes. After the Civil War, Kennedy's great-grandfather Leonidas Calhoun Kennedy inherited hundreds of acres of land in Catahoula when his mother died and turned to sharecropping to work the land.
=== Establishment === The British South Africa Police's Special Branch began pseudo operations to collect intelligence in 1966. The Rhodesian Army took part in a joint trial using these tactics with the British South Africa Police and Special Branch that year, but it was not successful for at that stage the black population was largely indifferent to the insurgents and so not able to provide intelligence on them. The ZANLA began to gain control over north-eastern Rhodesia from 1971, and considerably strengthened its influence over the population in the region over the next year. This led to the networks of informers who had provided information to the Rhodesian Government ceasing to do so, which made it difficult for the security forces to locate and counter the insurgents. In response, Special Branch began to establish pseudo teams in January 1973. The Rhodesian Army also formed two such teams in February; these comprised members of C Squadron 22 (Rhodesian) SAS, black soldiers from the Rhodesian African Rifles and former insurgents. These teams enjoyed success, leading to a decision to expand pseudo operations. Major Ronald Francis Reid-Daly was selected to command the unit that became the Selous Scouts in November 1973. He was personally selected for this role by Lieutenant General Peter Walls, the head of the Rhodesian Army. An initial group of 25 personnel were selected and trained at Makuti near Lake Kariba. The first troop completed training and began operations in January 1974, followed by two other troops in February and March that year.
Coleoids, a shell-less subclass of cephalopods (squid, cuttlefish, and octopuses), have complex pigment containing cells called chromatophores which are capable of producing rapidly changing color patterns. These cells store pigment within an elastic sac which produces the color seen from these cells. Coleoids can change the shape of this sac, called the cytoelastic sacculus, which then causes changes in the translucency and opacity of the cell. By rapidly changing multiple chromatophores of different colors, cephalopods are able to change the color of their skin at astonishing speeds, an adaptation that is especially notable in an organism that sees in black and white. Chromatophores are known to only contain three pigments, red, yellow, and brown, which cannot create the full color spectrum. However, cephalopods also have cells called iridophores, thin, layered protein cells that reflect light in ways that can produce colors chromatophores cannot. The mechanism of iridophore control is unknown, but chromatophores are under the control of neural pathways, allowing the cephalopod to coordinate elaborate displays. Together, chromatophores and iridophores are able to produce a large range of colors and pattern displays.
Sources: en.wikipedia.org
Although lipidomics is under the umbrella of the more general field of "metabolomics", lipidomics is itself a distinct discipline due to the uniqueness and functional specificity of lipids relative to other metabolites. In lipidomic research, a vast amount of information quantitatively describing the spatial and temporal alterations in the content and composition of different lipid molecular species is accrued after perturbation of a cell through changes in its physiological or pathological state. Information obtained from these studies facilitates mechanistic insights into changes in cellular function. Therefore, lipidomic studies play an essential role in defining the biochemical mechanisms of lipid-related disease processes through identifying alterations in cellular lipid metabolism, trafficking and homeostasis. The growing attention on lipid research is also seen from the initiatives underway of the LIPID Metabolites And Pathways Strategy (LIPID MAPS Consortium). and The European Lipidomics Initiative (ELIfe).
Volume, Area, Dihedral Angle Reporter (VADAR) is a freely available protein structure validation web server that was developed as a collaboration between Dr. Brian Sykes and Dr. David Wishart at the University of Alberta. VADAR consists of over 15 different algorithms and programs for assessing and validating peptide and protein structures from their PDB coordinate data. VADAR is capable of determining secondary structure (using three different algorithms), identifying and classifying six different types of beta turns, determining and calculating the strength of C=O -- N-H hydrogen bonds, calculating residue-specific accessible surface areas (ASA), calculating residue volumes, determining backbone and side chain torsion angles (phi, psi, omega and chi angles), assessing local structure quality (through numerous quality indices), evaluating global structure quality, and identifying residue "outliers" (residues with unusual structural features). The results have been validated through extensive comparison to published data and careful visual inspection. VADAR produces both text and graphical output with most of the quantitative data presented in easily viewed tables. In particular, VADAR's output is presented in a vertical, tabular format with most of the sequence data, residue numbering and any other calculated property or feature presented from top to bottom, rather than from left to right.
=== E-cigarettes === The American Lung Association listed use of flavored e-cigarettes as a risk factor for BO in 2016. Health Canada has, however, seen no cases as of 2023. Public Health England writes that the association has come about as "some flavourings used in e-liquids to provide a buttery flavour contain the chemical diacetyl… However, diacetyl is banned as an ingredient from e-cigarettes and e-liquids in the UK." The UK National Health Service's website states that "vaping does not cause 'popcorn lung'".
Gene expression in mammals is regulated by many cis-regulatory elements, including core promoters and promoter-proximal elements that are located near the transcription start sites of genes, upstream on the DNA (towards the 5' region of the sense strand). Other important cis-regulatory modules are localized in DNA regions that are distant from the transcription start sites. These include enhancers, silencers, insulators and tethering elements. Enhancers and their associated transcription factors have a leading role in the regulation of gene expression. Enhancers are genome regions that regulate genes. Enhancers control cell-type-specific gene expression programs, most often by looping through long distances to come in physical proximity with the promoters of their target genes. Multiple enhancers, each often tens or hundred of thousands of nucleotides distant from their target genes, loop to their target gene promoters and coordinate with each other to control gene expression. The illustration shows an enhancer looping around to come into proximity with the promoter of a target gene. The loop is stabilized by a dimer of a connector protein (e.g. dimer of CTCF or YY1). One member of the dimer is anchored to its binding motif on the enhancer and the other member is anchored to its binding motif on the promoter (represented by the red zigzags in the illustration). Several cell function-specific transcription factors (among the about 1,600 transcription factors in a human cell) generally bind to specific motifs on an enhancer.
Sources: en.wikipedia.org
Under the weight of this offensive, Chinese forces drove MacArthur's forces out of North Korea and captured Seoul, but were subsequently pushed back south of Pyongyang north of the 38th Parallel. The war also catalyzed the rapid modernization of the People's Liberation Army Air Force (PLAAF). In 1962, the PLA Ground Force also fought India in the Sino-Indian War. In a series of border clashes in 1967 with Indian troops, the PLA suffered heavy numerical and tactical losses. Before the Cultural Revolution, military region commanders tended to remain in their posts for long periods. The longest-serving military region commanders were Xu Shiyou in the Nanjing Military Region (1954–74), Yang Dezhi in the Jinan Military Region (1958–74), Chen Xilian in the Shenyang Military Region (1959–73), and Han Xianchu in the Fuzhou Military Region (1960–74). In May 1965 during the Cultural Revolution, PLA abandoned the use of the military ranks that it had adopted in 1955. The Central Military Commission had deemed that ranks were an expression of bourgeois right and hierarchy which led to individualist attitudes, inequality, and a sense of disunity. This was reversed in September 1988. The establishment of a professional military force equipped with modern weapons and doctrine was the last of the Four Modernizations announced by Zhou Enlai and supported by Deng Xiaoping. In keeping with Deng's mandate to reform, the PLA has demobilized millions of men and women since 1978 and has introduced modern methods in such areas as recruitment and manpower, strategy, and education and training.
=== Measuring coral health === To assess the threat level of coral, scientists developed a coral imbalance ratio, Log (Average abundance of disease-associated taxa / Average abundance of healthy associated taxa). The lower the ratio the healthier the microbial community is. This ratio was developed after the microbial mucus of coral was collected and studied.
== Ownership == The SCIRP website is operated by Wuhan Erwan Culture Communication Co., Ltd. Wuhan Erwan Culture Communication Co., Ltd is primarily owned by Wuhan Grand Technology Service Co., Ltd. Engineering Information Institute, a member or source content provider of SCIRP, is also owned by Wuhan Erwan Culture Communication Co., Ltd.
Sources: en.wikipedia.org
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.
The peptide was named after a protein fraction found in human gastric juice, and the shorter form was called body protection compound. That phrase was shortened to the abbreviation BPC. The number 157 refers to a laboratory designation used in the original isolation work.
Its sequence corresponds to a segment of a protein present in gastric secretions, but the material supplied for research is made synthetically. No commercial product is purified from human or animal tissue. The synthetic route is used because it gives a defined chain length and a reproducible sequence.
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.